相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。SARS-CoV-2 infection of primary human lung epithelium for COVID-19 modeling and drug discovery
Apoorva Mulay et al.
CELL REPORTS (2021)
Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
Delphine Planas et al.
NATURE (2021)
Increased morbidity of obese mice infected with mouse-adapted SARS-CoV-2
Ya-Nan Zhang et al.
CELL DISCOVERY (2021)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
In Vivo Delivery of Nucleic Acid-Encoded Monoclonal Antibodies
Ami Patel et al.
BIODRUGS (2020)
Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2
Qihui Wang et al.
CELL (2020)
Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection
Mihai G. Netea et al.
CELL (2020)
SARS-CoV-2 productively infects human gut enterocytes
Mart M. Lamers et al.
SCIENCE (2020)
A human monoclonal antibody blocking SARS-CoV-2 infection
Chunyan Wang et al.
NATURE COMMUNICATIONS (2020)
A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2
Rui Shi et al.
NATURE (2020)
Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells
Yunlong Cao et al.
CELL (2020)
Adenovirus delivery of encoded monoclonal antibody protects against different types of influenza virus infection
Xiang Wang et al.
NPJ VACCINES (2020)
A mouse model for SARS-CoV-2 infection by exogenous delivery of hACE2 using alphavirus replicon particles
Ya-Nan Zhang et al.
CELL RESEARCH (2020)
SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates
Gregory A. Poland et al.
LANCET (2020)
How mRNA therapeutics are entering the monoclonal antibody field
Lien Van Hoecke et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
A lipid-encapsulated mRNA encoding a potently neutralizing human monoclonal antibody protects against chikungunya infection
Nurgun Kose et al.
SCIENCE IMMUNOLOGY (2019)
An alphavirus-based therapeutic cancer vaccine: from design to clinical trial
Amrita Singh et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Systemic AAV vectors for widespread and targeted gene delivery in rodents
Rosemary C. Challis et al.
NATURE PROTOCOLS (2019)
Fate of PEGylated antibody fragments following delivery to the lungs: Influence of delivery site, PEG size and lung inflammation
Harshad P. Patil et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Engineered mRNA-expressed antibodies prevent respiratory syncytial virus infection
Pooja Munnilal Tiwari et al.
NATURE COMMUNICATIONS (2018)
Adeno-associated virus gene delivery of broadly neutralizing antibodies as prevention and therapy against HIV-1
Allen Lin et al.
RETROVIROLOGY (2018)
Elimination of large tumors in mice by mRNA-encoded bispecific antibodies
Christiane R. Stadler et al.
NATURE MEDICINE (2017)
Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge
Norbert Pardi et al.
NATURE COMMUNICATIONS (2017)
mRNA mediates passive vaccination against infectious agents, toxins, and tumors
Moritz Thran et al.
EMBO MOLECULAR MEDICINE (2017)
Self-replicating alphavirus RNA vaccines
Karl Ljungberg et al.
EXPERT REVIEW OF VACCINES (2015)
Enhancement of protein expression by alphavirus replicons by designing self-replicating subgenomic RNAs
Dal Young Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Intranasal Antibody Gene Transfer in Mice and Ferrets Elicits Broad Protection Against Pandemic Influenza
Maria P. Limberis et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Properties and use of novel replication-competent vectors based on Semliki Forest virus
Kai Rausalu et al.
VIROLOGY JOURNAL (2009)
An alphavirus replicon particle chimera derived from Venezuelan equine encephalitis and Sindbis viruses is a potent gene-based vaccine delivery vector
S Perri et al.
JOURNAL OF VIROLOGY (2003)
分享论文
